WS Data Solutions
Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Nurix Therapeutics, Inc. Common stock (NRIX)
Pharmaceutical Preparations
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
07/24/2020
Market Cap
1,444,758,917
Shares Outstanding
48,500,000
Weighted SO
48,503,768
Total Employees
N/A
Upcoming Earnings
10/10/2024
Beta
2.2240
Last Div
0.0000
Range
4.22-24.377
Chg
0.2700
Avg Vol
1010537
Mkt Cap
1444758917
Exch
NASDAQ
Country
US
Phone
415 660 5320
DCF Diff
16.4845
DCF
-6.2845
Div Yield
0.0000
P/S
23.1892
EV Multiple
-8.2739
P/FV
3.7744
Div Yield %
0.0000
P/E
-8.4795
PEG
-0.2212
Payout
0.0000
Current Ratio
5.5734
Quick Ratio
5.5734
Cash Ratio
1.4458
DSO
3.5151
DIO
0.0000
Op Cycle
3.5151
DPO
67.9064
CCC
-64.3913
Gross Margin
0.7573
Op Margin
-2.8747
Pretax Margin
-2.6455
Net Margin
-2.6484
Eff Tax Rate
-0.0697
ROA
-0.3229
ROE
-0.6778
ROCE
-0.4163
NI/EBT
1.0011
EBT/EBIT
0.9203
EBIT/Rev
-2.8747
Debt Ratio
0.0564
D/E
0.0777
LT Debt/Cap
0.0533
Total Debt/Cap
0.0721
Int Coverage
-22.7089
CF/Debt
-3.5060
Equity Multi
1.3786
Rec Turnover
103.8383
Pay Turnover
5.3750
Inv Turnover
0.0000
FA Turnover
1.3146
Asset Turnover
0.1219
OCF/Share
-1.6198
FCF/Share
-1.7780
Cash/Share
7.1041
OCF/Sales
-1.6218
FCF/OCF
1.0976
CF Coverage
-3.5060
ST Coverage
-12.7351
CapEx Coverage
-10.2423
Div&CapEx Cov
-10.2423
P/BV
3.7744
P/B
3.7744
P/S
23.1892
P/E
-8.4795
P/FCF
-13.0270
P/OCF
-13.8473
P/CF
-13.8473
PEG
-0.2212
P/S
23.1892
EV Multiple
-8.2739
P/FV
3.7744
DPS
0.0000